Fresenius Medical Care AG & Co. KGaA (FME) Given a €90.00 Price Target at Morgan Stanley

Morgan Stanley set a €90.00 ($94.74) price objective on Fresenius Medical Care AG & Co. KGaA (ETR:FME) in a research note published on Tuesday. The brokerage currently has a buy rating on the stock.

A number of other analysts have also recently commented on the stock. Bankhaus Lampe set a €80.00 ($84.21) price target on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a neutral rating in a research note on Monday, October 10th. Berenberg Bank set a €94.00 ($98.95) price target on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a buy rating in a research note on Wednesday, November 2nd. HSBC set a €83.00 ($87.37) price target on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a neutral rating in a research note on Tuesday, October 18th. Goldman Sachs Group, Inc. (The) set a €94.00 ($98.95) price target on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a buy rating in a research note on Friday, October 28th. Finally, J P Morgan Chase & Co set a €104.50 ($110.00) price target on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a buy rating in a research note on Thursday, January 5th. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and fourteen have issued a buy rating to the company’s stock. The company has an average rating of Buy and an average price target of €88.27 ($92.92).

Shares of Fresenius Medical Care AG & Co. KGaA (ETR:FME) traded down 1.719% on Tuesday, reaching €75.743. 2,865 shares of the company were exchanged. The stock has a market capitalization of €23.19 billion and a PE ratio of 19.781. Fresenius Medical Care AG & Co. KGaA has a 12-month low of €67.50 and a 12-month high of €85.52. The firm has a 50 day moving average price of €77.23 and a 200-day moving average price of €77.95.

TRADEMARK VIOLATION NOTICE: This article was first posted by Community Financial News and is the sole property of of Community Financial News. If you are viewing this article on another publication, it was illegally copied and republished in violation of U.S. and international copyright & trademark laws. The legal version of this article can be viewed at https://www.com-unik.info/2017/01/11/fresenius-medical-care-ag-co-kgaa-fme-given-a-90-00-price-target-at-morgan-stanley.html.

Fresenius Medical Care AG & Co. KGaA Company Profile

Fresenius Medical Care AG & Co KGaA (FMC AG & CO. KGAA) is a kidney dialysis company. The Company provides dialysis care and related services to persons suffering from end stage renal disease (ESRD), as well as other healthcare services. The Company operates through four segments: North America, Europe, Middle East, Africa (EMEA), Asia-Pacific and Latin America.

What are top analysts saying about Fresenius Medical Care AG & Co. KGaA? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Fresenius Medical Care AG & Co. KGaA and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit